Company InterCure Ltd.

Stocks

INCR

IL0011063760

Healthcare Facilities & Services

Business description: InterCure Ltd.

Sales by Activity: InterCure Ltd.

Geographical breakdown of sales: InterCure Ltd.

Executive Committee: InterCure Ltd.

Composition of the Board of Directors: InterCure Ltd.

Shareholders: InterCure Ltd.

Company details: InterCure Ltd.

Medical Farming

Sector

Income Statement and Estimates

Market Closed - TEL AVIV STOCK EXCHANGE 15:24:46 09/11/2026 GMT			5-day change	1st Jan Change
1,088.00 ^ILa	+4.02%		-16.88%	-32.76%

09-08	InterCure Regains Nasdaq Compliance	MT
08-24	InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI

InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.

Number of employees: 285

Fiscal Period: December	2021 (ILS)	2022 (ILS)	2023 (ILS)	2024 (ILS)	2025 (ILS)
Cannabis Segment	220M	389M	356M	239M	270M

See all business segments

Fiscal Period: December	2021 (ILS)	2022 (ILS)	2023 (ILS)	2024 (ILS)	2025 (ILS)
Israel	-	-	-	-	262M
Germany	-	-	-	-	8.15M

See all geographic segments

Manager	Title	Age	Since
Alexander Rabinovitch CEO	Chief Executive Officer	55	23/12/2019
Amos Cohen DFI	Director of Finance/CFO	47	29/02/2020
Itai Kabiljo LAW	General Counsel	-	31/03/2022
Yisrael Gewirtz AUD	Comptroller/Controller/Auditor	49	31/12/2013

See INTERCURE LTD. governance

Director	Title	Age	Since
Lennie Michelson Grinbaum BRD	Director/Board Member	50	02/09/2015
David Salton BRD	Director/Board Member	67	13/12/2014
Alexander Rabinovitch CHM	Chairman	55	12/02/2025
Gideon Hirschfeld BRD	Director/Board Member	60	22/09/2018
Alon Shmuel Granot BRD	Director/Board Member	65	31/10/2020

Composition of the Board of Directors

Name	Stocks	%	Valuation
Alexander Rabinovitch 25.01 %	2,962,512	25.01 %	16 M ILa
Yael Figel 6.951 %	823,389	6.951 %	4 M ILa
Yaron Jacobi 6.425 %	761,083	6.425 %	4 M ILa
Ayalon Mutual Funds Ltd. 0.9606 %	113,786	0.9606 %	620 661 ILa
IBI Mutual Funds Management (1978) Ltd. 0.8674 %	102,750	0.8674 %	560 463 ILa

List of INTERCURE LTD. shareholders

InterCure Ltd.

85 Medinat ha-Yehudim Street

4676670, Herzliya

+972 7 746 05012

http://www.intercure.co

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTERCURE LTD.	+4.02%	-16.88%	-52.60%	-49.14%	40.78M
CVS HEALTH CORPORATION	+1.67%	-3.68%	+7.93%	+27.73%	109B
HCA HEALTHCARE, INC.	+2.00%	+7.94%	+5.93%	+121.87%	105B
NATERA, INC.	+3.13%	-15.45%	+60.54%	+605.86%	46.46B
FRESENIUS SE & CO. KGAA	+0.41%	+8.03%	+10.16%	+105.72%	33.1B
LABCORP HOLDINGS INC.	+1.43%	+4.57%	+47.13%	+82.02%	30.19B
QUEST DIAGNOSTICS INCORPORATED	+1.58%	+3.53%	+44.66%	+97.26%	28.57B
TENET HEALTHCARE CORPORATION	+2.00%	+7.48%	+40.80%	+448.80%	23B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.37%	+1.18%	-17.81%	-16.07%	19.97B
IHH HEALTHCARE	+0.39%	-0.13%	-5.72%	+31.58%	16.76B
Average	+1.65%	-0.52%	+14.10%	+145.56%	41B
Weighted average by Cap.	+1.67%	+0.93%	+18.96%	+153.42%

See all sector performances

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical Farming

Projected Income Statement - Annual - InterCure Ltd.

More financial data